Latest Press Releases
September 10, 2024
Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate
June 26, 2024
Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
June 18, 2024
Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy
In the news
Interview with patient caregiver at the XVII Conference on Epilepsy Therapies & Diagnostics Development (ETDD)
(with permission from ETDD, patient and caregiver)
August 15, 2024
A Conversation with CEO Cory Nicholas on Neurona Therapeutics’ Recent RMAT Designation
March 29, 2024
Brain-cell Transplants are the Newest Experimental Epilepsy Treatment
February 14, 2024
Neurona Therapeutics Raises $120M Financing, Cell Therapy Shows Positive Outcomes in CIRM-Funded Trial
